Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Acromegaly epidemiology and demographics

Introduction

Overview

Overview

The prevalence of acromegaly is estimated to be 2.8 – 13.7 per 100.000 individuals worldwide. In the United States, the incidence of acromegaly is 0.11 per 100,000 indvidual. Acromegaly affects men and women equally.

Epidemiology and Demographics

Epidemiology and Demographics

Incidence

  • The incidence of acromegaly is approximately 0.2 – 1.1 per 100,000 individuals worldwide.[1][2][3]

Prevalence

  • The prevalence of acromegaly is approximately 2.8 – 13.7 per 100,000 individuals worldwide.[4][5]

Age

  • The incidence of acromegaly increases with age; the mean age at diagnosis of acromegaly is 40 years in males.
  • The mean age at diagnosis of acromegaly is 45 years in females.

Race

  • There is no racial predilection to acromegaly.

Gender

  • Acromegaly affects men and women equally.[6]

Developed Countries

  • In the United States, acromegaly is very rare. The incidence of acromegaly in the United States is 0.11 per 100,000 individual.
  • In Iceland, the incidence of acromegaly is 0.7 per 100,000 individual.[7]
References

References

  1. ↑ Bengtsson BA, Edén S, Ernest I, Odén A, Sjögren B (1988). “Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984”. Acta Med Scand. 223 (4): 327–35. PMID 3369313.
  2. ↑ Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N (2017). “Epidemiology of acromegaly: review of population studies”. Pituitary. 20 (1): 4–9. doi:10.1007/s11102-016-0754-x. PMC 5334410. PMID 27743174.
  3. ↑ Dal J, Feldt-Rasmussen U, Andersen M, Kristensen LØ, Laurberg P, Pedersen L; et al. (2016). “Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study”. Eur J Endocrinol. 175 (3): 181–90. doi:10.1530/EJE-16-0117. PMID 27280374.
  4. ↑ Bengtsson BA, Edén S, Ernest I, Odén A, Sjögren B (1988). “Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984”. Acta Med Scand. 223 (4): 327–35. PMID 3369313.
  5. ↑ Holdaway IM, Rajasoorya C (1999). “Epidemiology of acromegaly”. Pituitary. 2 (1): 29–41. PMID 11081170.
  6. ↑ Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG (1994). “Acromegaly. Clinical and biochemical features in 500 patients”. Medicine (Baltimore). 73 (5): 233–40. PMID 7934807.
  7. ↑ Hoskuldsdottir GT, Fjalldal SB, Sigurjonsdottir HA (2015). “The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013”. Pituitary. 18 (6): 803–7. doi:10.1007/s11102-015-0655-4. PMID 25893613.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]